Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆

Updated 12 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Chengdu

← All China trials

Every active and recruiting clinical study with an investigative site in China — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

9

Recruiting now

14

Active studies

Recruiting Phase 1

Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China

Healthy Participants Study
Chengdu Zenitar Biomedical Technology Co., Ltd · started 2026-07-23

📍 Chengdu

NCT07757152 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children

Respiratory Syncytial Virus Infection
Simcere Pharmaceutical Co., Ltd · started 2026-03-11

📍 Xiamen · Changsha · Chengdu · Hangzhou

NCT07402512 on ClinicalTrials.gov ↗

Recruiting Phase 1

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors

Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · started 2026-01-22

📍 Beijing · Fuzhou · Meizhou · Shanghai · Chengdu

NCT07269145 on ClinicalTrials.gov ↗

Recruiting Phase 3

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Multiple Sclerosis
Sanofi · started 2026-01-14

📍 Beijing · Chengdu · Jiazhuang

NCT07325292 on ClinicalTrials.gov ↗

Recruiting Phase 2

A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse

Smoking
Eli Lilly and Company · started 2025-11-03

📍 Beijing · Chengdu · Chongqing · Hangzhou · Linhai · Ningbo

NCT07223840 on ClinicalTrials.gov ↗

Starting soon Phase 2

Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma

Kaposiform Hemangioendothelioma
West China Hospital · started 2025-09-13

📍 Chengdu

NCT07131644 on ClinicalTrials.gov ↗

Recruiting Phase 2

Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage

Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
Huashan Hospital · started 2025-06-18

📍 Beijing · Chengdu · Shanghai

NCT07026994 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Metastatic Non-small Cell Lung Cancer
AstraZeneca · started 2024-10-04

📍 Baoding · Beijing · Bengbu · Changchun · Changsha · Chengdu

NCT06417814 on ClinicalTrials.gov ↗

Active

Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant

Diabetic Macular Edema
AbbVie · started 2023-10-30

📍 Shenzhen · Wuhan · Xi'an · Qingdao · Chengdu

NCT05978622 on ClinicalTrials.gov ↗

Recruiting

Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)

Acute Aortic Syndrome, Aortic Dissection Type a
Nanjing Medical University · started 2022-07-01

📍 Bengbu · Guangzhou · Nanjing · Yangzhou · Jinan · Chengdu

NCT05339529 on ClinicalTrials.gov ↗

By invitation Phase 3

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Stereotypical Prolonged Seizures
UCB Biopharma SRL · started 2022-02-03

📍 Beijing · Changchun · Chengdu · Chongqing · Fuzhou · Guangzhou

NCT05076617 on ClinicalTrials.gov ↗

Recruiting Phase 3

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Myasthenia Gravis
Janssen Research & Development, LLC · started 2021-07-15

📍 Beijing · Changchun · Changsha · Chengdu · Fuzhou · Guangzhou

NCT04951622 on ClinicalTrials.gov ↗

Active Phase 2

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Solid Tumors
Hoffmann-La Roche · started 2021-01-18

📍 Beijing · Chengdu · Shanghai · Tianjin · Xi'an

NCT04589845 on ClinicalTrials.gov ↗

Active Phase 2/Phase 3

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Relapsed/Refractory Diffuse Large B-cell Lymphoma
Karyopharm Therapeutics Inc · started 2020-09-03

📍 Nanjing · Suzhou · Huangpu · Xuhui · Chengdu · Hangzhou

NCT04442022 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

Beijing · 65 Guangzhou · 30 Shanghai · 28 Fuzhou · 14 Chengdu · 14 Changsha · 13 Shenzhen · 12 Hangzhou · 11 Tianjin · 10 Wuhan · 9 Chongqing · 8 Changchun · 7

Browse by condition

Breast Cancer · 5 Artificial Intelligence (AI) · 2 Healthy · 2 Aneurysmal Subarachnoid Hemorrhage · 2 Prostate Cancer · 2 Nasopharyngeal Cancinoma (NPC) · 2 Solid Tumors · 2 Healthy Participants · 2 Ischemic Stroke · 2 Wet Age-related Macular Degenerat… · 2 Plaque Psoriasis · 2 Solid Tumor · 2 Colorectal Cancer · 2 Gastric Cancer · 2 Lung Cancer (NSCLC) · 2 Pulmonary Function · 2

Cite this page

Priya Life Science (2026). Clinical Trials in China Tracker. Available at: https://priyalifescience.com/clinical-trials-china/city/chengdu (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Chinese site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.